UiPath shares have rebounded from a steep 2026 slide after the automation firm posted its first GAAP profit and repositioned around AI agents.

Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

UiPath PATH is expanding its automation portfolio with Maestro Case, a new capability designed to help enterprises manage ...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a ...

PATH's AI orchestration push and growing enterprise adoption make it a more compelling buy over NU despite Nubank's strong ...

Trupeer AI, the workflow knowledge layer for teams and AI agents, today announced the appointment of Raghu Subramanian as President and Chief Business Officer, as the company accelerates its next ...

Good day, everyone. My name is Megan, and I will be your conference operator today. At this time, I would like to welcome you to the UiPath's First Quarter 2027 Earnings Conference Call. [Operator ...

UiPath's latest product session was billed as an investor briefing, but the most consequential announcement was a pivot in who - or what - the platform is actually built for. Most enterprise AI ...

Hi, everyone. Thanks for joining us today. I'm Allise Furlani UiPath's Investor Relations team, and I'd like to welcome you to our virtual fireside chat and product strategy overview. We'll begin with ...

UiPath PATH1.39%increase; up pointing triangle reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year revenue ...

AI is reshaping the CHRO role, requiring HR leaders to become AI strategists and bridge people, technology, and data in today ...